Many pharma companies already made U.S. investment promises, says Citi's Geoff Meacham

CNBC’s “Closing Bell Overtime” team discusses President Trump's plan to impose a 100% tariff on “all any branded or patented Pharmaceutical Product” entering the U.S. with Geoff Meacham of Citi Research.